» Articles » PMID: 27966708

Meso-Acetoxymethyl BODIPY Dyes for Photodynamic Therapy: Improved Photostability of Singlet Oxygen Photosensitizers

Overview
Publisher Springer
Specialties Biology
Chemistry
Date 2016 Dec 15
PMID 27966708
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We report two BODIPY based photosensitizers (Br2BOAc and I2BOAc) featuring an acetoxymethyl substituent at the meso-position. These photosensitizers show improved photostability against singlet oxygen, when compared to a BODIPY photosensitizer lacking the acetoxymethyl group. Both compounds were evaluated for photodynamic therapy against HeLa cells and photodynamic inactivation against E. coli bacteria. We show that the compounds readily embed in the lipid membranes of HeLa cervical cancer cells and efficiently induced light-dependent apoptosis at nanomolar concentration. Also, both compounds showed a substantial degree of photoinactivation of E. coli bacteria when used at low micromolar concentrations.

Citing Articles

BODIPYs in PDT: A Journey through the Most Interesting Molecules Produced in the Last 10 Years.

Malacarne M, Gariboldi M, Caruso E Int J Mol Sci. 2022; 23(17).

PMID: 36077597 PMC: 9456687. DOI: 10.3390/ijms231710198.


Photodynamic treatment of melanoma cells using aza-dipyrromethenes as photosensitizers.

Castro K, Costa L, Guieu S, Biazzotto J, da Neves M, Faustino M Photochem Photobiol Sci. 2020; 19(7):885-891.

PMID: 32662457 DOI: 10.1039/d0pp00114g.


Effect of Aryl-, Halogen-, and Ms-Aza-Substitution on the Luminescent Properties and Photostability of Difluoroborates of 2,2'-Dipyrrometenes.

Kritskaya A, Berezin M, Antina E, Vyugin A J Fluoresc. 2019; 29(4):911-920.

PMID: 31240540 DOI: 10.1007/s10895-019-02403-2.


An updated overview on the development of new photosensitizers for anticancer photodynamic therapy.

Zhang J, Jiang C, Figueiro Longo J, Azevedo R, Zhang H, Muehlmann L Acta Pharm Sin B. 2018; 8(2):137-146.

PMID: 29719775 PMC: 5925394. DOI: 10.1016/j.apsb.2017.09.003.